Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
Angelis, A.
, Lange, A. & Kanavos, P.
(2018).
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.
European Journal of Health Economics,
19(1), 123-152.
https://doi.org/10.1007/s10198-017-0871-0
, Lange, A. & Kanavos, P.
(2018).
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.
European Journal of Health Economics,
19(1), 123-152.
https://doi.org/10.1007/s10198-017-0871-0
Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the incorporation of supplementary evidence and criteria that capture additional dimensions of value.
